array(3) { ["company_details"]=> array(13) { ["name"]=> string(27) "Tekla World Healthcare Fund" ["slug"]=> string(36) "b56a5-us-tekla-world-healthcare-fund" ["logo"]=> NULL ["description"]=> string(834) "Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website." ["address_street"]=> string(20) "100 Federal St FL 19" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2015-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(57) "https://www.teklacap.com/funds/thw/info/fund-information/" ["industry_codes"]=> array(1) { [0]=> string(101) "Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices" } ["employee_count"]=> int(3) ["article_count"]=> int(154) } ["articles"]=> array(4) { [0]=> array(7) { ["title_en"]=> string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn" ["snippet_en"]=> string(300) "BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic" ["url"]=> string(101) "https://www.fintechnews.org/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn/" ["image_url"]=> NULL ["source"]=> string(15) "fintechnews.org" ["publication_date"]=> string(10) "2023-10-29" ["categories"]=> array(5) { [0]=> string(25) "Business Model Resilience" [1]=> string(10) "Divestment" [2]=> string(20) "Business Development" [3]=> string(22) "Business Restructuring" [4]=> string(11) "Acquisition" } } [1]=> array(7) { ["title_en"]=> string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn" ["snippet_en"]=> string(297) "Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under" ["url"]=> string(120) "https://www.nasdaq.com/press-release/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn-2023-10-27" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(5) { [0]=> string(25) "Business Model Resilience" [1]=> string(10) "Divestment" [2]=> string(20) "Business Development" [3]=> string(22) "Business Restructuring" [4]=> string(11) "Acquisition" } } [2]=> array(7) { ["title_en"]=> string(70) "Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc." ["snippet_en"]=> string(190) "Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds." ["url"]=> string(118) "https://www.nasdaq.com/press-release/tekla-funds-approve-new-investment-advisory-agreements-with-abrdn-inc.-2023-10-27" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(5) { [0]=> string(13) "Collaboration" [1]=> string(25) "Business Model Resilience" [2]=> string(15) "Deals & Tenders" [3]=> string(19) "Investment Requests" [4]=> string(18) "General Investment" } } [3]=> array(7) { ["title_en"]=> string(78) "abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM" ["snippet_en"]=> string(269) "abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts." ["url"]=> string(84) "https://finance.yahoo.com/news/abrdn-acquire-us-specialist-healthcare-221500989.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/965c9901-84c5-4864-8fbd-8c2564370b75" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-06-20" ["categories"]=> array(3) { [0]=> string(25) "Business Model Resilience" [1]=> string(11) "Acquisition" [2]=> string(18) "General Investment" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(18) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(9) } [3]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [6]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [9]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } } } b56a5-us-tekla-world-healthcare-fund

Tekla World Healthcare Fund

Location

Massachusetts

Founded

2015-01-26

Website

https://www.teklacap.com/funds/thw/info/fund-information/

Articles

154 Articles

Category

Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices

Description

Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website.

Articles

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-10-29 (fintechnews.org)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-06-30 (nasdaq.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under

Read more
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

2023-06-30 (nasdaq.com)

Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds.

Read more
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM

2023-06-20 (yahoo.com)

abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM

abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.

Read more

Newsletter subscription